RT Journal Article
SR Electronic
T1 Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003237
DO 10.1136/jitc-2021-003237
VO 9
IS 11
A1 Nalawade, Saisha A
A1 Shafer, Paul
A1 Bajgain, Pradip
A1 McKenna, Mary K
A1 Ali, Arushana
A1 Kelly, Lauren
A1 Joubert, Jarrett
A1 Gottschalk, Stephen
A1 Watanabe, Norihiro
A1 Leen, Ann
A1 Parihar, Robin
A1 Vera Valdes, Juan Fernando
A1 Hoyos, Valentina
YR 2021
UL http://jitc.bmj.com/content/9/11/e003237.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.